HealthEquity, Inc. (NASDAQ:HQY) CEO Jon Kessler Sells 33,765 Shares

HealthEquity, Inc. (NASDAQ:HQY) CEO Jon Kessler sold 33,765 shares of the business’s stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total value of $2,694,784.65. Following the transaction, the chief executive officer now owns 126,635 shares in the company, valued at $10,106,739.35. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

HealthEquity Stock Up 0.3 %

HealthEquity stock opened at $79.72 on Thursday. HealthEquity, Inc. has a twelve month low of $48.86 and a twelve month high of $84.49. The stock’s fifty day simple moving average is $79.76 and its 200-day simple moving average is $73.25. The company has a current ratio of 4.76, a quick ratio of 4.93 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $6.84 billion, a P/E ratio of 124.56, a P/E/G ratio of 1.34 and a beta of 0.53.

Wall Street Analyst Weigh In

A number of research analysts recently commented on HQY shares. Barrington Research reiterated an “outperform” rating and issued a $100.00 price objective on shares of HealthEquity in a report on Friday, March 22nd. KeyCorp upped their price objective on HealthEquity from $85.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, March 22nd. BTIG Research upped their price objective on HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, March 20th. Raymond James upped their price objective on HealthEquity from $90.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, December 13th. Finally, Royal Bank of Canada upped their price objective on HealthEquity from $90.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, March 20th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $92.55.

Institutional Trading of HealthEquity

Large investors have recently modified their holdings of the stock. Comerica Bank grew its stake in shares of HealthEquity by 82,280.3% during the third quarter. Comerica Bank now owns 58,490 shares of the company’s stock worth $4,273,000 after purchasing an additional 58,419 shares in the last quarter. Natixis Advisors L.P. grew its stake in shares of HealthEquity by 7.2% during the third quarter. Natixis Advisors L.P. now owns 17,664 shares of the company’s stock worth $1,290,000 after purchasing an additional 1,180 shares in the last quarter. Portside Wealth Group LLC acquired a new position in shares of HealthEquity during the second quarter worth $5,162,000. Gotham Asset Management LLC acquired a new stake in shares of HealthEquity during the third quarter worth about $1,103,000. Finally, Loomis Sayles & Co. L P grew its stake in HealthEquity by 57.8% during the 3rd quarter. Loomis Sayles & Co. L P now owns 399,683 shares of the company’s stock worth $29,197,000 after buying an additional 146,372 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.